Open AccessFactors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
Author(s) -
Vasiliki Georgakopoulou,
Dimitrios Basoulis,
Pantazis Voutsinas,
Sotiria Makrodimitri,
Stamatia Samara,
Maria Triantafyllou,
Irene Eliadi,
Georgios Karamanakos,
Chrysovalantis V. Papageorgiou,
Amalia Anastasopoulou,
Aikaterini Bitsani,
Olga Kampouropoulou,
Ioanna Eleftheriadou,
Aikaterini Gkoufa,
Demetrios�� Spandidos,
Petros Papalexis,
Nikolaos V. Sipsas
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11660
Subject(s) - tocilizumab , medicine , comorbidity , retrospective cohort study , pneumonia , vaccination , mortality rate , immunology , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom